PKC iota (PRKCI) Human siRNA Oligo Duplex (Locus ID 5584)
CAT#: SR321426
PRKCI (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Need single siRNA in bulk?
Get a free quote
SR321426 is the updated version of SR303741.
CNY 4,090.00
货期*
4周
规格
Cited in 6 publications. |
Product images
经常一起买 (3)
Specifications
Product Data | |
Purity | HPLC purified |
Quality Control | Tested by ESI-MS |
Sequences | Available with shipment |
Stability | One year from date of shipment when stored at -20°C. |
# of transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
Note | Single siRNA duplex (10nmol) can be ordered. |
Reference Data | |
RefSeq | NM_002740 |
Synonyms | DXS1179E; nPKC-iota; PKCI |
Components | PRKCI (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each (Locus ID 5584)Included - SR30004, Trilencer-27 Universal Scrambled Negative Control siRNA Duplex - 2 nmolIncluded - SR30005, RNAse free siRNA Duplex Resuspension Buffer - 2 ml |
Summary | This gene encodes a member of the protein kinase C (PKC) family of serine/threonine protein kinases. The PKC family comprises at least eight members, which are differentially expressed and are involved in a wide variety of cellular processes. This protein kinase is calcium-independent and phospholipid-dependent. It is not activated by phorbolesters or diacylglycerol. This kinase can be recruited to vesicle tubular clusters (VTCs) by direct interaction with the small GTPase RAB2, where this kinase phosphorylates glyceraldehyde-3-phosphate dehydrogenase (GAPD/GAPDH) and plays a role in microtubule dynamics in the early secretory pathway. This kinase is found to be necessary for BCL-ABL-mediated resistance to drug-induced apoptosis and therefore protects leukemia cells against drug-induced apoptosis. There is a single exon pseudogene mapped on chromosome X. [provided by RefSeq, Jul 2008] |
Performance Guranteed | OriGene guarantees that at least two of the three Dicer-Substrate duplexes in the kit will provide at least 70% or more knockdown of the target mRNA when used at 10 nM concentration by quantitative RT-PCR when the TYE-563 fluorescent transfection control duplex (cat# SR30002) indicates that >90% of the cells have been transfected and the HPRT positive control (cat# SR30003) provides 90% knockdown efficiency. For non-conforming siRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the siRNA kit. To arrange for a free replacement with newly designed duplexes, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled siRNA control (quantitative RT-PCR data required). |
Citations (6)
The use of this RNAi has been cited in the following citations: |
---|
Atypical PKCs activate Vimentin to facilitate prostate cancer cell motility and invasion
,Ratnayake, WS;Apostolatos, CA;Breedy, S;Dennison, CL;Hill, R;Acevedo-Duncan, M;,
Cell adhesion & migration
,PubMed ID 33525953
[PRKCI]
|
The interruption of atypical PKC signaling and Temozolomide combination therapy against glioblastoma
,Dey, A;Islam, S;Patel, R;Acevedo-Duncan, M;,
Cellular Signalling
,PubMed ID 33147518
[PRKCI]
|
c‑Jun and FOXO1 mediate the expression of oncogenic PKC‑ι in human prostate cancer cells with an interplay between NF‑κB, IL‑8 and ICAM‑1
,RATNAYAKE, W;APOSTOLATOS, C;BREEDY, S;ACEVEDO‑DUNCAN, M;,
World Acad Sci J
[PRKCI]
|
The modulation of actin dynamics via atypical Protein Kinase-C activated Cofilin regulates metastasis of colorectal cancer cells
,Islam, SMA;Patel, R;Bommareddy, RR;Khalid, KM;Acevedo-Duncan, M;,
Cell Adh Migr
,PubMed ID 30417717
[PRKCI]
|
Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors
,Ratnayake, WS;Apostolatos, CA;Apostolatos, AH;Schutte, RJ;Huynh, MA;Ostrov, DA;Acevedo-Duncan, M;,
Cell Adh Migr
,PubMed ID 29781749
[PRKCI]
|
FOXO1 regulates oncogenic PKC-ι expression in melanoma inversely to c-Jun in an autocrine manner via IL-17E and ICAM-1 activation
,Ratnayke, W;Apostolatos, C;Breedy, S;Apostolatos, A;Acevedo-Duncan, M;,
wasj
[PRKCI]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...